US6184211B1
(en)
*
|
1993-11-30 |
2001-02-06 |
Methylgene Inc. |
Inhibition of DNA methyltransferase
|
US6645943B1
(en)
*
|
1994-10-25 |
2003-11-11 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US6608035B1
(en)
*
|
1994-10-25 |
2003-08-19 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US7074768B2
(en)
|
1995-08-17 |
2006-07-11 |
Idera Pharmaceuticals, Inc. |
Modified protein kinase A-specific oligonucleotides and methods of their use
|
AU3355297A
(en)
*
|
1996-05-22 |
1997-12-09 |
Mcgill University |
Specific inhibitors of dna methyltransferase enzyme
|
US6268137B1
(en)
|
1996-05-22 |
2001-07-31 |
Methylgene, Inc. |
Specific inhibitors of DNA methyl transferase
|
AU6592496A
(en)
*
|
1996-07-22 |
1998-02-10 |
Hybridon, Inc. |
Compositions and methods for treating specific gene expression-related diseases and disorders in humans
|
AU8125098A
(en)
|
1997-05-30 |
1998-12-30 |
Mcgill University |
Dna methyltransferase genomic sequences and antisense oligonucleotides
|
US6020318A
(en)
*
|
1997-05-30 |
2000-02-01 |
Methylgene, Inc. |
DNA methyltransferase genomic sequences and antisense oligonucleotides
|
US7138384B1
(en)
|
1997-08-29 |
2006-11-21 |
The Regents Of The University Of California |
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
|
ATE294388T1
(de)
*
|
1997-08-29 |
2005-05-15 |
Univ California |
Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
US6066625A
(en)
*
|
1998-02-03 |
2000-05-23 |
Methylgene, Inc. |
Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
|
ATE526406T1
(de)
|
1998-03-20 |
2011-10-15 |
Commw Scient Ind Res Org |
Kontrolle der genexpression
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
US7368551B2
(en)
|
1998-06-25 |
2008-05-06 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
US7342108B2
(en)
*
|
1998-06-25 |
2008-03-11 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
EP1108018A1
(de)
*
|
1998-08-31 |
2001-06-20 |
AstraZeneca AB |
Menschliches deltex-ähnliches gene zdx
|
US6953783B1
(en)
*
|
1998-10-19 |
2005-10-11 |
Methylgene, Inc. |
Modulation of gene expression by combination therapy
|
WO2000027795A1
(en)
|
1998-11-12 |
2000-05-18 |
Invitrogen Corporation |
Transfection reagents
|
EP1147204A1
(de)
*
|
1999-01-28 |
2001-10-24 |
Medical College Of Georgia Research Institute, Inc. |
Zusammensetzung und verfahren zur in vivo und in vitro abschwächung der genexpression mittels dobbelsträngigem rna
|
WO2000063364A2
(en)
*
|
1999-04-21 |
2000-10-26 |
American Home Products Corporation |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
US20040138168A1
(en)
*
|
1999-04-21 |
2004-07-15 |
Wyeth |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
US20030078216A1
(en)
*
|
1999-05-03 |
2003-04-24 |
Macleod A. Robert |
Inhibition of histone deactylase
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
EP1130120A3
(de)
*
|
2000-01-26 |
2004-02-04 |
Nisshinbo Industries, Inc. |
Methode zum Trennen und Sammeln von Nukleinsäuren
|
AU2001240375A1
(en)
*
|
2000-03-17 |
2001-10-03 |
Benitec Australia Limited |
Genetic silencing
|
EP1438404A2
(de)
|
2000-03-24 |
2004-07-21 |
Methylgene, Inc. |
Hemmung von spezifischen isoformen der histondeacetylase
|
AU2001249622B2
(en)
|
2000-03-30 |
2007-06-07 |
Massachusetts Institute Of Technology |
RNA sequence-specific mediators of RNA interference
|
US20040006036A1
(en)
*
|
2000-04-12 |
2004-01-08 |
Gmr, A Delaware Corporation |
Silencing transcription by methylation
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
EP2336166A1
(de)
|
2000-10-12 |
2011-06-22 |
University Of Rochester |
Zusammensetzungen die die Proliferation von Krebszellen hemmen
|
JP2004521614A
(ja)
*
|
2000-10-27 |
2004-07-22 |
インヴィトロジェン コーポレーション |
アンチセンスオリゴヌクレオチドを真核細胞に導入する方法
|
HU230458B1
(hu)
|
2000-12-01 |
2016-07-28 |
Europäisches Laboratorium für Molekularbiologie (EMBL) |
Az RNS interferenciát közvetítő kis RNS molekulák
|
CA2369944A1
(en)
*
|
2001-01-31 |
2002-07-31 |
Nucleonics Inc. |
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
|
BR0209056A
(pt)
*
|
2001-04-20 |
2004-08-10 |
Wyeth Corp |
Derivados de heterociclilóxi-, -tióxi- e -aminobenzazol como ligantes de 5-hidroxitriptamina-6
|
CN1293073C
(zh)
*
|
2001-04-20 |
2007-01-03 |
惠氏公司 |
作为5-羟色胺-6配体的杂环基烷氧基-、-烷硫基-和-烷基氨基吲哚衍生物
|
GB2392911A
(en)
*
|
2001-05-11 |
2004-03-17 |
Methylgene Inc |
Inhibitors of dna methyltransferase isoforms
|
US20040266718A1
(en)
*
|
2001-08-06 |
2004-12-30 |
Zuomei Li |
Inhibition of specific histone deacetylase isoforms
|
EP1572168B1
(de)
|
2002-02-06 |
2010-05-26 |
Vicor Technologies, Inc. |
Anti-infarkt-moleküle
|
EP1534729A2
(de)
*
|
2002-02-26 |
2005-06-01 |
University of Utah Research Foundation |
Mit bluthochdruck und virusknospung assoziierte nedd4l-varianten
|
EP1575992A4
(de)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
Chimäre proteine aus proteintransduzierender domäne/deaminase, verwandte verbindungen und deren verwendungen
|
ITMI20031714A1
(it)
*
|
2003-09-05 |
2005-03-06 |
Gentium Spa |
Formazioni ad azione antitumorale.
|
US7855323B2
(en)
*
|
2004-02-10 |
2010-12-21 |
Monsanto Technology Llc |
Recombinant DNA for gene suppression
|
US20060075515A1
(en)
|
2004-08-11 |
2006-04-06 |
Luethy Michael H |
Enhanced zein reduction in transgenic corn seed
|
EP1574499A1
(de)
*
|
2004-03-08 |
2005-09-14 |
DKFZ Deutsches Krebsforschungszentrum |
DNA-Methylerungshemmer in Tumorzellen
|
US8029815B2
(en)
*
|
2004-04-28 |
2011-10-04 |
Elford Howard L |
Methods for treating or preventing restenosis and other vascular proliferative disorders
|
MX2007008065A
(es)
*
|
2004-12-30 |
2008-03-04 |
Todd M Hauser |
Composiciones y metodos para modular la expresion genica usando oligonucleotidos autoprotegidos.
|
JP2008531647A
(ja)
*
|
2005-03-03 |
2008-08-14 |
ゲンチウム エスピーエー |
抗腫瘍作用を有する製剤
|
DE202005004135U1
(de)
*
|
2005-03-11 |
2005-05-19 |
Klocke Verpackungs-Service Gmbh |
Mehrkomponentenverpackung mit Applikator
|
ES2716874T3
(es)
|
2005-03-23 |
2019-06-17 |
Genmab As |
Anticuerpos contra cd38 para el tratamiento del mieloma múltiple
|
WO2006107751A2
(en)
*
|
2005-04-01 |
2006-10-12 |
Methylgene, Inc. |
Combined therapy utilizing reduction of dna methyltansferase expression and/or activity and interferon
|
MX2007014616A
(es)
|
2005-05-20 |
2009-08-12 |
Methylgene Inc |
Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos.
|
CA2625891A1
(en)
|
2005-10-14 |
2007-04-26 |
Carlton D. Donald |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
US20080064718A1
(en)
*
|
2006-03-22 |
2008-03-13 |
Saavedra Oscar M |
Inhibitors of protein tyrosine kinase activity
|
US20080004273A1
(en)
*
|
2006-05-30 |
2008-01-03 |
Stephane Raeppel |
Inhibitors of protein tyrosine kinase activity
|
EP1872787A1
(de)
*
|
2006-06-27 |
2008-01-02 |
Gentium S.p.A. |
Verwendung von Defibrotide als Heparanasehemmer
|
EP2560001B1
(de)
|
2006-09-21 |
2016-04-13 |
University of Rochester |
Zusammensetzungen und Verfahren für eine Proteinverlagerungstherapie für myotone Dystrophie
|
US20080255155A1
(en)
*
|
2006-10-18 |
2008-10-16 |
Stephane Raeppel |
Kinase inhibitors and uses thereof
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
JP2010512327A
(ja)
|
2006-12-11 |
2010-04-22 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
病的血管形成および脈管透過性の処置用の組成物および方法
|
EP1982722A1
(de)
*
|
2007-04-16 |
2008-10-22 |
Gentium S.p.A. |
Verwendung von Oligotid zur Behandlung von Nierenerkrankungen
|
EP2030615A3
(de)
*
|
2007-08-13 |
2009-12-02 |
ELFORD, Howard L. |
Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen
|
AU2008296478B9
(en)
|
2007-08-28 |
2015-03-19 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
AU2008296487A1
(en)
|
2007-08-28 |
2009-03-12 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
WO2010070380A2
(en)
*
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
EP2103689A1
(de)
*
|
2008-03-19 |
2009-09-23 |
Gentium S.p.A. |
Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
US8816095B2
(en)
*
|
2008-08-15 |
2014-08-26 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
WO2010045095A1
(en)
|
2008-10-14 |
2010-04-22 |
Ning Xi |
Compounds and methods of use
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
EP2580243B1
(de)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antikörper gegen menschliches cd38
|
CN103260627A
(zh)
|
2010-11-12 |
2013-08-21 |
真蒂奥姆有限公司 |
去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
|
RU2568258C2
(ru)
|
2011-02-28 |
2015-11-20 |
Саншайн Лейк Фарма Ко., Лтд |
Замещенные соединения хинолина и способы их использования
|
JP2013198425A
(ja)
*
|
2012-03-24 |
2013-10-03 |
Kanagawa Univ |
オリゴヌクレオチドの製造方法
|
DK2864496T4
(da)
|
2012-06-22 |
2021-01-04 |
Gentium S R L |
Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid
|
WO2014022116A2
(en)
|
2012-07-28 |
2014-02-06 |
Calitor Sciences, Llc |
Substituted pyrazolone compounds and methods of use
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途
|
WO2014093688A1
(en)
|
2012-12-12 |
2014-06-19 |
1Massachusetts Institute Of Technology |
Compositions and methods for functional nucleic acid delivery
|
AU2014219256B2
(en)
|
2013-02-21 |
2017-02-16 |
Sunshine Lake Pharma Co., Ltd. |
Heteroaromatic compounds as PI3 kinase modulators
|
WO2015077566A1
(en)
|
2013-11-21 |
2015-05-28 |
Huang Zhen |
Methods for structural determination of selenium derivatized nucleic acid complexes
|
WO2016011203A1
(en)
|
2014-07-15 |
2016-01-21 |
Life Technologies Corporation |
Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
|
BR112017001860A2
(pt)
|
2014-07-31 |
2018-02-27 |
Uab Research Foundation |
peptídeo sintético, composição farmacêutica, métodos, regime de dosagem, e, anticorpo monoclonal
|
EP3026122A1
(de)
|
2014-11-27 |
2016-06-01 |
Gentium S.p.A. |
Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid
|
WO2017067447A1
(en)
|
2015-10-19 |
2017-04-27 |
Sunshine Lake Pharma Co., Ltd. |
A salt of egfr inhibitor, crystalline form and uses thereof
|
JP2019527229A
(ja)
|
2016-07-28 |
2019-09-26 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Gpr156変異体及びその使用
|
US11123435B2
(en)
|
2016-08-03 |
2021-09-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
TLR9 targeted therapeutics
|
KR102619197B1
(ko)
|
2017-01-23 |
2024-01-03 |
리제너론 파마슈티칼스 인코포레이티드 |
Hsd17b13 변종 및 이것의 용도
|
CA3065938A1
(en)
|
2017-06-05 |
2018-12-13 |
Regeneron Pharmaceuticals, Inc. |
B4galt1 variants and uses thereof
|
AU2018328120A1
(en)
|
2017-09-06 |
2020-03-19 |
Regeneron Pharmaceuticals, Inc. |
Single immunoglobulin interleukin-1 receptor related (SIGIRR) variants and uses thereof
|
RU2020112313A
(ru)
|
2017-09-07 |
2021-10-08 |
Ридженерон Фармасьютикалз, Инк. |
Варианты члена 1 семейства 14 переносчиков растворенных веществ (slc14a1)и их применение
|
US12016314B2
(en)
|
2017-09-08 |
2024-06-25 |
Ohio State Innovation Foundation |
MicroRNA inhibitor therapy in systemic lupus erythematosus
|
EP3695012B1
(de)
|
2017-10-11 |
2023-03-08 |
Regeneron Pharmaceuticals, Inc. |
Hemmung von hsd17b13 in der behandlung der lebererkrankung bei patienten, die die pnpla3-i148m-variation exprimieren
|
EP3697807A1
(de)
|
2017-10-16 |
2020-08-26 |
Regeneron Pharmaceuticals, Inc. |
Cornulin (crnn)-varianten und ihre verwendungen
|
US11957687B2
(en)
|
2019-07-02 |
2024-04-16 |
Regeneron Pharmaceuticals, Inc. |
Modulators of HSD17B13 and methods of use thereof
|